Idorsia Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | n/a |
Management average tenure | 7.5yrs |
Board average tenure | 3.6yrs |
Recent management updates
Recent updates
CEO
Idorsia has no CEO, or we have no data on them.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive VP & CFO | 7.9yrs | no data | 0.056% CHF 66.3k | |
Executive VP & Chief Scientific Officer | 7.9yrs | no data | 6.79% CHF 8.1m | |
Executive VP & Chief Medical Officer | no data | no data | 0.11% CHF 129.0k | |
Executive VP & Head of Global Clinical Development | 5.8yrs | no data | 0.0071% CHF 8.4k | |
Senior VP and Head of Investor Relations & Corporate Communications | 7.5yrs | no data | no data | |
Senior VP | 2.1yrs | no data | no data | |
Senior VP & Head of Global Human Resources | 7.5yrs | no data | no data | |
Senior VP & Head of Technical Operations | no data | no data | no data | |
Senior VP & Head of Drug Discovery Biology | no data | no data | no data | |
Senior VP & Head of Drug Discovery Chemistry | no data | no data | no data |
7.5yrs
Average Tenure
59.5yo
Average Age
Experienced Management: IDIAZ's management team is seasoned and experienced (7.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Non-Executive Director | 3.6yrs | CHF 149.37k | 0.020% CHF 24.1k | |
Chairman of the Board | less than a year | CHF 1.98m | 19.04% CHF 22.7m | |
Non-Executive Director | 4.6yrs | CHF 156.82k | 0.021% CHF 25.1k | |
Non-Executive Director | 4.6yrs | CHF 174.78k | 0.054% CHF 64.3k | |
Non-Executive Director | less than a year | no data | no data | |
Vice-Chairman & Lead Independent Director | 5.6yrs | CHF 344.19k | 0.069% CHF 82.0k | |
Non-Executive Director | 1.6yrs | CHF 117.54k | 0.012% CHF 14.5k | |
Non-Executive Director | 4.6yrs | CHF 172.30k | 0.025% CHF 29.8k | |
Non-Executive Director | 3.6yrs | CHF 161.88k | 0.025% CHF 29.3k |
3.6yrs
Average Tenure
65yo
Average Age
Experienced Board: IDIAZ's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 14:39 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Idorsia Ltd is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Maria Maldonado | Bank Vontobel AG |
Jean-Philippe Bertschy | Bank Vontobel AG |
Rosie Turner | Barclays |